Preimplantation Genetic Testing Webinars

An estimated 48.5 million couples suffer from infertility worldwide, driving up usage of assisted reproductive technologies around the globe. As a result, preimplantation genetic testing (PGT) has become commonplace in in vitro fertilization (IVF) research to evaluate the status of an embryo.

 

Commonly used PGT testing solutions:

  • Preimplantation genetic testing-aneuploidy (PGT-A)—detects aneuploidies, or chromosomal abnormalities, across all 24 chromosomes (22 autosomes and the X and Y chromosomes)
  • Preimplantation genetic testing-monogenic (PGT-M)—identifies specific genetic variants in a single gene associated with known predisposition within the family

 

Advancements in next-generation sequencing (NGS) methods enable simple, scalable, and innovative sample-to-answer workflow solutions for PGT-A and PGT-M. NGS delivers fast results from precious samples, without the complexities that come with traditional genetic analysis tools.

 

Hear what your peers are saying about NGS and preimplantation genetic testing:

Clinical webinars

Current status of niPGT-A

Dr. Gary Nakhuda, Founder and Codirector, Olive Fertility Centre

Dr. Gary Nakhuda discusses the current status of niPGT-A, including its pitfalls and potential in clinical use.

How NGS solutions are advancing preimplantation genetic testing - Part 3 The clinician’s view

Meera Shah, MD, Reproductive Endocrinology and Infertility Specialist, Nova IVF

Listen to Meera Shah, MD, Nova IVF, discuss case studies involving polyploid testing with PGT.

PGT: The Clinical Perspective

Dr. Gary Nakhuda, Founder and Codirector, Olive Fertility Centre

Gary Nakhuda provides a clinical perspective on the benefits, current limitations, and unresolved issues in preimplantation genetic testing for aneuploidy (PGT-A).

IVF laboratory webinars

Viability of blastocyst stage embryos developed from abnormally fertilized oocytes

Cengiz Cinnioglu, PhD, Founder and General Manager, Luminary Genetics

Dr. Cinnioglu discusses the evolution of preimplantation genetic testing and how single nucleotide polymorphism detections has impacted IVF by sharing findings from Luminary Genetic's clinical data.

A SNP in time: genotyping dubiously fertilized embryos

Dr. Anil Biricik, Scientific Director of IVF‑PGT, Eurofins Genoma Italy

Dr. Birick covers the application of molecular techniques to detect ploidy abnormalities in IVF, covering experiences and data on embryos with different fertilization patterns, emphasizing the importance of correct observation strategies for predicting polyploidy.

First moves

Dr. George Liperis, Founder and Scientific Director at Embryorigin Fertility Centre

Dr. Liperis defined the fertilization events that occur during the first 24 hours, discussed the features observed in zygotes, and their potential as markers for embryo selection.

Recommendations for IVF laboratory for the most effective cfDNA analysis during non-invasive PGT

Dr. Anil Biricik, Scientific Director of IVF-PGT Eurofins Genoma Italy Images

Dr. Anil Biricik shares recommendations from the in vitro fertilization (IVF) laboratory for effective cfDNA analysis during niPGT.

Practical experiences on PGT, tubing, and genetic sampling of the blasocoel

Dr. Evrim Unsal, Director of Molecular Genetics, Mikrogen Genetic Diagnostics Center

Dr Evrim Unsal shares practical experiences on PGT, tubing, and genetic sampling of the blastocoel.

PGT-A: The Embryologist's Perspective

Catherine Welch, MBA, TS(ABB), Founder and Managing Director, Sequence46

Catherine Welch provides an embryologist’s perspective on workflow, no results, rebiopsy, and mosaicism during preimplantation genetic testing for aneuploidy (PGT-A).

Incorporating PGT-A in the IVF program: an IVF centre perspective

Andrea Tzu-Hsuan Chuang, M.Sc., Director of NGS Lab, Stork Fertility Center, Taiwan

Conventional fertility centers combine clinical and embryology (andrology) departments. Increasingly, centers are adding a genetic laboratory for in-house molecular experiments. Preimplantation genetic testing for aneuploidy (PGT-A) is the most common service. Since 2014, next-generation sequencing (NGS) has been the primary platform for comprehensive chromosome screening (CCS). This talk introduces setting up an NGS workflow in a private fertility center, enhancing convenience, efficiency, and reliability with step-by-step modifications.

Utility of offering combined PGT-A and PGT-M: a laboratory perspective

Alpana Razdan, Ph.D., Vice President and Head of Lab Services, Genestrings Diagnostic Centre Pvt Ltd., India

Integrated sequencing technology has enabled the use of both the PGT-A and PGT-M simultaneously. Reports have documented that the embryos screened for aneuploidy as well as for single gene or monogenic disorders, using the integrated technique of PGT-A and PGT-M have successfully improved the pregnancy rates from 45% to 70%.

Combined PGT-A and PGT-M analysis from a single biopsy in an IVF practice: experience, learning and benefits

Tee Sze Tian, MSc, Clinical Embryology Group, Chief Embryologist, TMC Fertility Centre

Learn the powerful benefits of running in-house PGT-A and PGT-M on the same NGS platform with a single embryo biopsy. In-house control creates flexibility to respond to each patient scenario, thereby reducing unnecessary costs and time. And combining analyses from the same sample limits impact to the embryo, while producing comprehensive findings for greatest probability of pregnancy success and genetically healthy offspring.

How to start an NGS lab for reproductive health testing

Alain Rico, Senior Product Manager, Thermo Fisher Scientific

Our presenters, Alain Rico and Matt Osentoski, will take you through the requirements needed to add NGS to your laboratory. This will include space requirements, equipment, personnel, and validation steps.

Genetic counseling webinars

How NGS solutions are advancing preimplantation genetic testing - Part 2 The genetic counselor’s view

Amy Jordan, MS, LCGC, Director of Reproductive Genetics, NextGen Genetics

Amy Jordan, MS, LCGC, Luminary (formerly NextGen Genetics) discusses how improvements in PGT directly affect patient care.

PGT-A: The Genetic Counselor's Perspective

Emily Mounts, MS, CGC, Fertility Genetic Counselor, Focus Genetic Consulting

Emily Mounts discusses current challenges faced by genetic counselors in preimplantation genetic testing for aneuploidy (PGT-A).

For Research Use Only. Not for use in diagnostic procedures.

CN: 64695